US life sciences tools company
US life sciences tools company
Bio-Techne shareholders have approved the $11.3 billion acquisition by Merck KGaA of Darmstadt, Germany, clearing a key procedural milestone as the deal moves toward a close expected by late 2026 …
You must be logged in to post a comment.